Skip to main content

LMR Partners LLP

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1578621 LONDON, X0

Position in CAPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
8 quarters on record

Derivatives in CAPR

reported options exposure · as of Jun 30, 2026
CallValue
$2,819,768
CallShares
117,100
PutValue
$558,656
PutShares
23,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,819,768 117,100
2026-06-30 $558,656 23,200
2026-03-31 $2,647,840 87,100
2025-12-31 $8,793,642 304,700
2025-12-31 $6,412,692 222,200
2025-09-30 $2,377,137 329,700
2025-09-30 $2,106,041 292,100
2025-06-30 $2,050,545 206,500
2025-06-30 $5,416,815 545,500
2025-03-31 $1,755,650 185,000
2025-03-31 $521,950 55,000
2024-12-31 $2,094,840 151,800
2024-09-30 $2,308,878 151,800